Safety and efficacy of catheter ablation of atrial fibrillation in the very elderly (≥80 years old): Insights from the UC San Diego AF Ablation Registry

被引:5
|
作者
Aldaas, Omar [1 ]
Darden, Douglas [1 ]
Mylavarapu, Praneet [1 ]
Aldaas, Amer [2 ]
Han, Frederick [1 ]
Hoffmayer, Kurt [1 ]
Krummen, David [1 ]
Ho, Gordon [1 ]
Raissi, Farshad [1 ]
Feld, Gregory [1 ]
Hsu, Jonathan [1 ,3 ]
机构
[1] Univ Calif San Diego Hlth Syst, Div Cardiac Electrophysiol, La Jolla, CA USA
[2] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA
[3] Univ Calif San Diego, Dept Med, Div Cardiol, Cardiac Electrophysiol Sect, 9452 Med Ctr Dr,3rd Floor,Room 3E-417, La Jolla, CA 92037 USA
关键词
atrial fibrillation; catheter ablation; complications; hospitalizations; mortality; very elderly; TERM CLINICAL-EFFICACY; RISK; ANTICOAGULATION; PREVALENCE; MANAGEMENT; STROKE;
D O I
10.1002/clc.24137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundCatheter ablation improves outcomes in symptomatic atrial fibrillation (AF) patients. However, its safety and efficacy in the very elderly (>= 80 years old) is not well described.HypothesisAblation of AF in the very elderly is safe and effective.MethodsWe performed a retrospective study of all patients who underwent catheter ablation enrolled in the University of California, San Diego AF Ablation Registry. The primary outcome was freedom from atrial arrhythmias on or off antiarrhythmic drugs (AADs).ResultsOf 847 patients, 42 (5.0%) were 80 years of age or greater with a median age of 81.5 (80-82.3) and 805 (95.0%) were less than 80 years of age with a median age of 64.4 (57.6-70.2). Among those who were >= 80 years old, 29 were undergoing de novo ablation (69.0%), whereas in the younger cohort, 518 (64.5%) were undergoing de novo ablation (p = .548). There were no statistically significant differences in fluoroscopy (p = .406) or total procedure times (p = .076), AAD use (p = .611), or procedural complications (p = .500) between groups. After multivariable adjustment, there were no statistically significant differences in recurrence of any atrial arrhythmias on or off AAD (adjusted hazard ratio [AHR]: 0.75; 95% confidence interval [CI]: 0.45-1.23; p = .252), all-cause hospitalizations (AHR: 0.86; 95% CI: 0.46-1.60; p = .626), or all-cause mortality (AHR: 4.48; 95% CI: 0.59-34.07; p = .147) between the very elderly and the younger cohort.ConclusionIn this registry analysis, catheter ablation of AF appears similarly effective and safe in patients 80 years or older when compared to a younger cohort. Kaplan-Meier plots of long-term recurrence of atrial arrhythmias on or off antiarrhythmic drugs (excluding a 3-month postprocedural blanking period), long-term rate of all-cause hospitalizations, and long-term rate of all-cause mortality. Patients who were 80 years of age or older and a younger cohort are compared.image
引用
收藏
页码:1488 / 1494
页数:7
相关论文
共 50 条
  • [31] Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
    Dong, Zhimin
    Hou, Xiaoxia
    Du, Xin
    He, Liu
    Dong, Jianzeng
    Ma, Changsheng
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [32] Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
    Dong, Zhimin
    Hou, Xiaoxia
    Du, Xin
    He, Liu
    Dong, Jianzeng
    Ma, Changsheng
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [33] Efficacy and Safety of Catheter Ablation for Persistent or Permanent Atrial Fibrillation
    Muraoka, Soichi
    Mitsutake, Chiharu
    Takashima, Hideo
    Nakashima, Hideko
    Yasuda, Tomoo
    Matsumoto, Naomichi
    Kumagai, Koichiro
    Saku, Keijiro
    JOURNAL OF ARRHYTHMIA, 2007, 23 (03) : 229 - 235
  • [34] Efficacy and safety of catheter ablation for atrial fibrillation in patients with cancer
    Ganatra, S.
    Abraham, S.
    Parikh, R.
    Kamenetsky, D.
    Patel, R.
    Dani, S.
    Chaudhry, G.
    Resnic, F.
    Shah, S.
    Venesy, D.
    Patten, R.
    Neilan, T.
    Reynolds, M.
    Hook, B.
    Nohria, A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3278 - 3278
  • [35] Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians
    Tan, Hong-wei
    Wang, Xin-hua
    Shi, Hai-feng
    Yang, Guo-shu
    Zhou, Li
    Gu, Jia-ning
    Jiang, Wei-feng
    Liu, Xu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (01) : 147 - 148
  • [36] Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry
    Schleberger, Ruben
    Metzner, Andreas
    Kuck, Karl-Heinz
    Andresen, Dietrich
    Willems, Stephan
    Hoffmann, Ellen
    Deneke, Thomas
    Eckardt, Lars
    Brachmann, Johannes
    Hochadel, Matthias
    Senges, Jochen
    Rillig, Andreas
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (06):
  • [37] Catheter ablation of atrial fibrillation in patients with concomitant sinus bradycardia-Insights from the German Ablation Registry
    Zylla, Maura M.
    Brachmann, Johannes
    Lewalter, Thorsten
    Hoffmann, Ellen
    Kuck, Karl-Heinz
    Andresen, Dietrich
    Willems, Stephan
    Hochadel, Matthias
    Senges, Jochen
    Katus, Hugo A.
    Thomas, Dierk
    JOURNAL OF ELECTROCARDIOLOGY, 2016, 49 (02) : 117 - 123
  • [38] Efficacy and safety of atrial fibrillation ablation in patients aged ≥80 years: a retrospective study
    Sakamoto, Yusuke
    Osanai, Hiroyuki
    Tanaka, Yuki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2025, 87 (01) : 37 - 50
  • [39] Efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in the elderly patients over 75-years old: A propensity-matched analysis
    Baek, Y. S.
    Kim, T. H.
    Uhm, J. S.
    Joung, B. Y.
    Lee, M. H.
    Pak, H. N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 197 - 197
  • [40] Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry
    Usuda, Keisuke
    Kato, Takeshi
    Tsuda, Toyonobu
    Tada, Hayato
    Niwa, Satoru
    Usui, Soichiro
    Sakata, Kenji
    Hayashi, Kenshi
    Furusho, Hiroshi
    Kawashiri, Masaaki
    Takamura, Masayuki
    Otsuka, Takayuki
    Suzuki, Shinya
    Hirata, Akio
    Murakami, Masato
    Takami, Mitsuru
    Kimura, Masaomi
    Fukaya, Hidehira
    Nakahara, Shiro
    Shimizu, Wataru
    Iwasaki, Yu-ki
    Hayashi, Hiroshi
    Harada, Tomoo
    Nakajima, Ikutaro
    Okumura, Ken
    Koyama, Junjiroh
    Tokuda, Michifumi
    Yamane, Teiichi
    Momiyama, Yukihiko
    Tanimoto, Kojiro
    Soejima, Kyoko
    Nonoguchi, Noriko
    Ejima, Koichiro
    Hagiwara, Nobuhisa
    Harada, Masahide
    Sonoda, Kazumasa
    Inoue, Masaru
    Kumagai, Koji
    Hayashi, Hidemori
    Satomi, Kazuhiro
    Yazaki, Yoshinao
    Watari, Yuji
    Arai, Masaru
    Watanabe, Ryuta
    Yokoyama, Katsuaki
    Matsumoto, Naoya
    Nagashima, Koichi
    Okumura, Yasuo
    HEART AND VESSELS, 2022, 37 (02) : 327 - 336